• Uzmanlık Alanları: Allojeneik ve Otolog Kök Hücre Nakli, Terapötik Aferez, Febril Nötropeni

Eğitim ve Uzmanlık
1987 - 1993 - Ankara Üniversitesi Tıp Fakültesi - Lisans 
1994 - 1999 - Gazi Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı - İç Hastalıkları İhtisası
2000 - 2002 - Ankara Numune E.A. Hastanesi Hematoloji Kliniği, Hematoloji Yan Dal İhtisası
2005 - 2015 - Gazi Üniversitesi Tıp Fakültesi Hematoloji Bilim Dalı, Kök Hücre Nakli Eğitimi

Deneyim
Aralık 1993- Haziran 1994, S.B. 70. Yıl Ana Çocuk Sağlığı ve Aile Planlaması Merkezi Mecburi Hizmet
Mart 1999- Nisan 2000, Ankara Bayındır Tıp Merkezi, İç Hastalıkları Uzmanı
Mayıs 2003- Eylül 2004, Ankara Numune Eğitim ve Araştırma Hastanesi, Hematoloji Uzmanı        
Eylül 2004- Ocak 2005, Gazi Üniversitesi Tıp Fakültesi Hematoloji Uzmanı
Ocak 2005- Nisan 2010, Yardımcı Doçent; Gazi Üniversitesi Tıp Fakültesi Hematoloji B.D.
Nisan 2010 - Doçent; Gazi Üniversitesi Tıp Fakültesi Hematoloji B.D.
Ocak 2016 - Profesör; Bahçeşehir Üniversitesi Tıp Fakültesi
Yurtdışı Deneyim
Fred Hutchinson Cancer Research Center; Kemik İliği Nakil Programı Uzun Dönem Takip Birimi Seattle 2013; 1 yıl süre ile nakil sonrası uzun dönem komplikasyonların takip ve tedavisi ile ilgili eğitim

Mesleki Üyelikler
Türk Hematoloji Derneği
Türk Aferez Derneği

 

 

                                 

Akı Z, Kotiloğlu G, Özyılkan Ö. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin (Letter). Am J Gastroenterol, 95(4), 1093- 4 (2000).

Yılmaz M, Dagdas S, Güler N, Akı SZ, Aköz AG, Özet G, Aylı M, Sarıtas U. Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers. Hematology, 8(6), 393- 396 (2003).

Güler N, Yılmaz S, Ayaz S, Yılmaz M, Akı Z, Dağdaş S, Gökmen A, Özet G. The platelet derived growth factor level (PDGF) in Hodgkin’s disease and non-Hodgkin’s lymphoma and its relationship disease activation. Hematology, 10 (1), 53- 57 (2005).

 Yagcı M, Acar K, Sucak GT, Akı Z, Bozdayı G, Haznedar R. A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues. Leuk Lymphoma, 47(8), 1608- 1612 (2006).

Yılmaz M, Dagdas S, Akı SZ, Güler N, Aköz AG, Erdin Z, Alanoglu G, Ozet G. The relation between plasminogen activator inhibitor activity and disease activation in acute myeloblastic leukaemia patients. Clin Lab Haematol,  28 (5), 313- 316 (2006).

Sucak GT, Aki SZ, Yagci M, Yegin ZA, Ozkurt ZN, Haznedar R. Treatment of sinusoidal obstruction syndrome with defibrotide: a single center experience. Transplantation Proceedings, 39 (5), 1558- 1563 (2007).

Sucak GT, Aki Z, Or M. Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion. Can J Ophthalmol, 42 (4), 632- 3 (2007).

Yegin ZA, Akı S, Sucak G, Yagci M. Cytarabin induced non cardiogenic pulmonary edema in a case of acute lymphoblastic leukemia. Int J Lab Hematol, 29(6), 482- 483 (2007).

Sucak GT, Yegin ZA, Ozkurt ZN, Akı SZ, Karakan T, Akyol G. The role of liver biopsy in the workup of liver dysfunction late after stem cell transplantation: is the role of iron overload understimated. Bone Marrow Transplantation, 42 (7), 461- 467 (2008).

Aki ZŞ, Sucak GT, Yeğin ZA, Güzel Ö, Erbaş G, Şenol E. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation. Transplantation Proceedings, 40 (5), 1579- 1585 (2008).

Sucak GT, Ozkurt ZN, Akı Z, Yağcı M, Çengel A, Haznedar R. Cardiac systolic function in patients receiving hematopoietic stem cell transplantation: risk factors for posttransplantation cardiac toxicity. Transplantation Proceedings, 40(5), 1586- 1590 (2008).

Yenicesu I, Dilsiz G, Sucak G, Aki Z. BT- online: an innovated and promising computer assisted transfusion system. Med Sci Monit, 14(8), MT21- 6 (2008).

Akı Z, Aksoy O, Sucak G, Kuruoğlu R, Yağcı M. Miller- Fisher syndrome associated with chronic lymphocytic leukemia. Neurol India, 56(2), 198- 200 (2008).

Konca C, Özkurt ZN, Deger M, Akı Z, Yağcı M. Extranodal multifocal Rosai- Dorfman disease: response to 2- chlorodeoxyadenosine treatment. Int J Hematol, 89 (1), 58- 62 (2009).

Mutluay R, Akı SZ, Erten Y, Konca C, Yagci M, Marit G, Sindel S. Membranoproliferative glomerulonephritis and light- chain nephropathy in association with chronic lymphocytic leukemia. Clin Nephrol, 70 (6), 527- 31 (2008).

Akı SZ, Sucak GT, Ozkurt ZN, Yeğin ZA, Yağcı M, Haznedar R. Allogeneic stem cell transplantation for severe aplastic anemia: Graft rejection remains a problem. Transfus Apher Sci, 40 (1), 5- 11 (2009).

Cetiner S, Sucak GT, Kahraman SA, Akı SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab 27 (4); 435- 443 (2009)

Akı SZ, Sucak GT, Paşaoğlu H, Ozkurt ZN, Yegin ZA, Ofluoğlu E, Yağcı M, Haznedar R. Thrombopoietic cytokine & p- selectin levels in multiple myeloma patients undergoing autologous stem cell transplantation; the decrease in post- transplantation p- selectin levels may predict the degree of maximum response. Clin Lymphoma Myeloma 9 (3): 229- 233; 2009.

Ozkurt ZN, Sucak GT, Akı SZ, Yağcı M, Erdem O. Bortezomib- induced perivascular dermatitis in a patient with multiple myeloma. Cutan Ocul Toxicol 28 (3): 141- 143; 2009.

Kocer B, Sucak G, Kuruoglu R, Akı Z, Haznedar R, Erdogmus NI. Clinical and electrophysiological evaluation of patients with thalidomide- induced neuropathy. Acta Neurol Belg 109 (2): 120- 126; 2009.

Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT. Impact of ABO- incompatible donor on early and late outcome of hematopoietic stem cell transplantation. Transplant Proc 2009; 41 (9): 3851- 3858.

Ozyilmaz E, Aydogdu M, Sucak G, Aki SZ, Ozkurt ZN, Yegin ZA, Kokturk N. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: th role of iron overload. Bone Marrow Transplant 2010 Feb 1;

Sucak G, Suyani E, Ozkurt Z, Yeğin Z, Aki Z, Yagci M. Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance. Hematol Oncol 2010 Feb 12.

Tunçcan OG, Yegin ZA, Ozkurt ZN, Erbaş G, Akı SZ, Senol E, Yağcı M, Sucak G. High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates. Int J Infect Dis 2010; Sep;14 Suppl 3:e104-7.

Ceneli O, Ozkurt ZN, Acar K, Rota S, Akı SZ, Yeğin ZA, Yağcı M, Ozenirler S, Sucak GT. Hepatitis B- related events in autologous hematopoietic stem cell transplantation. World J Gastroenterol 2010; 16 (14): 1765- 1771.

Yegin ZA, Ozkurt ZN, Akı SZ, Sucak GT. Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation. Transfus Apher Sci 2010; 42 (3): 239- 245.

Ceneli O, Ozkurt ZN, Acar K, Rota S, Akı SZ, Yeğin ZA, Yağcı M, Ozenirler S, Sucak GT. Hepatitis B- related events in autologous hematopoietic stem cell transplantation. World J Gastroenterol 2010 Apr 14;16(14):1765-71.

Yegin ZA, Ozkurt ZN, Akı SZ, Sucak GT. Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation. Transfus Apher Sci 2010; 42 (3): 239- 45.

Sucak GT, Yegin ZA, Ozkurt ZN, Akı SZ, Yagci M. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation. Transplant Proc. 2010; 42(5): 1841- 8.

Ozkurt ZN, Yegin ZA, Suyanı E, Akı SZ, Acar K, Yagcı M, Sucak GT. Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation. J Clin Apher 2010; 25 (5): 280- 286.

Yağci M, Ozkurt ZN, Yeğin ZA, Aki Z, Sucak GT, Haznedar R. Hepatitis B virus reactivation in HBV- DNA negative ad positive patients with hematological malignancies. Hematology 2010; 15(4): 240- 4.

Suyanı E, Akı SZ, Yegin ZA, Ozkurt ZN, Altındal S, Akyürek N, Yagci M, Sucak GT. The impact of bone marow fibrosis on the outcome of hematopoietic stem cell transplantation. Transplant Proc 2010; 42 (7): 2713- 9.

Çeneli Ö, Akı ŞZ, Küçük BÇ, Tokçaer AB, Kuruoğlu R, Yağcı M. Autonomic nervous system dysfunction and serum levels of neurotoxic and neurotrophic cytokines in patients with cobalamin deficiency. Turk J Hematol 2010; 27 (4): 250- 256.

Suyanı E, Sucak GT, Akı SZ; Yeğin ZA, Ozkurt ZN, Yağcı M. Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT. Ann Hematol 2011; 90 (6): 685- 91.

Suyanı E, Akı Z, Güzel O, Altındal S, Senol E, Sucak G. H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving. Transplant Infect Dis 2011; 13 (2): 208- 12.

Haznedar R, Akı SZ, Akdemir OU, Ozkurt ZN, Ceneli O, Yağcı M, Sucak GT, Unlü M. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/ computed tomography in predicting survival in multiple myeloma. Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1046-53.

Yegin ZA, Paşaoğlu H, Aki SZ, Özkurt ZN, Demirtaş C, Yağci M, Acar K, Sucak GT. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation. Int J Lab Hematol. 2011Aug;33(4):414-23.

Sucak GT, Özkurt ZN, Suyani E, Yaşar DG, Akdemir ÖÜ, Aki Z, Yeğin ZA, Yağci M, Kapucu ÖL. Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival. Ann Hematol. 2011 Nov;90(11):1329-36.

Sucak GT, Aki SZ, Yüzbaşioğlu B, Akyürek N, Yağci M, Bağriaçik U, Haznedar R. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant. Leuk Lymphoma. 2011 Jul;52(7):1281-9.

Tunçcan ÖG, Aki ŞZ, Akyürek N, Sucak G, Şenol E. Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation. J Infect Dev Ctries. 2011 May 28;5(5):406-9.

Akı SZ, Paşaoğlu H, Yeğin ZA, Suyanı E, Demirtaş CY, Ozkurt ZN, Yağcı M, Sucak GT. Impact of prohepcidin levels and iron parameters on early post- transplantation toxicities. Hematology. 2011 Sep;16(5):284-90.

Mirza EI, Mutluay R, Suyani E, Okyay GU, Akyurek N, Aki SZ, Derici U, Arinsoy T. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient. Exp Clin Transplant. 2011 Dec;9(6):425-8.

Sucak GT, Suyanı E, Baysal NA, Altındal S, Cakar MK, Akı SZ, Yeğin ZA, Sanlıer N. The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning. Int J Hematol. 2012; 95(1):95-101.

Sucak GT, Yaşar DG, Yegin ZA, Ergün MA, Ozkurt ZN, Aki ŞZ, Güntekin S. The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2012 Aug;91(8):1281-7.

Tekgündüz E, Altuntaş F, Sıvgın S, Akı SZ, Dönmez A, Topçuoğlu P, Yıldırım R, Baysal NA, Ayyıldız E, Yüksel MK, Sarı I, Tombuloğlu M, Unal A, Ilhan O. Plerixafor use in patients with previous mobilization failure: A multicenter experience. Transfus Apher Sci. 2012 Aug;47(1):77-80.

Aydoğdu M, Ozyilmaz E, Köktürk N, Arzu Yeğin Z, Nur Özkurt Z, Sahika Aki Z, Sucak G. Is there any relationship between pulmonary function tests and post-transplant complications of allogeneic hematopoetic stem cell transplantation? Minerva Med. 2012 Jun;103(3):189-98.

Yenicesu I, Sucak G, Dilsiz G, Akı SZ, Yeğin ZA. Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion. Indian J Hematol Blood Transfus. 2011 Sep;27(3):146-51.

Akı SZ, Pamukçuoğlu M, Bağrıaçık U, Sucak GT. Encephalopathy: an unusual neurologic complication of autologous hematopoietic stem cell transplant in patients with multiple myeloma with renal failure. Leuk Lymphoma. 2012 Nov 6. [Epub ahead of print] PubMed PMID: 23039261.

Akı ŞZ, Suyanı E, Bildacı Y, Çakar MK, Baysal NA, Sucak GT. Prognostic role of pre-transplantation serum C-reactive protein levels in patients with acute leukemia undergoing myeloablative allogeneic stem cell transplantation. Clin Transplant. 2012 Sep-Oct;26(5):E513-21. doi: 10.1111/ctr.12028. PubMed PMID: 23061760.

Cakar MK, Suyanı E, Sucak GT, Altındal S, Akı SZ, Acar K, Yağcı M, Rota S, Ozenirler S. HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey. Ann Hematol. 2012 Nov 11. [Epub ahead of print] PubMed PMID: 23143119.

Sucak GT, Cakar MK, Suyanı E, Akı Z, Altındal SE, Acar K. Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey. Hematology. 2013 Jan 25. [Epub ahead of print] PubMed PMID: 23394351.

 Türkoglu M, Erdem GU, Suyanı E, Sancar ME, Yalçın MM, Aygencel G, Akı Z, Sucak G. Acute respiratory distress syndrome in patients with hematological malignancies. Hematology. 2012 Nov 15. [Epub ahead of print] PubMed PMID: 23321772.

Sucak GT, Çakar MK, Suyanı E, Akı Z, Altındal Ş, Acar K. Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey. Hematology. 2013 Sep;18(5):269-76.

Keser I, Suyani E, Aki SZ, Sucak AG. The positive impact of regular exercise program on stem cell mobilization prior to autologous stem cell transplantation. Transfus Apher Sci. 2013 Oct;49(2):302-6.

Keser I, Suyani E, Yosmaoglu HB, Aki SZ, Turkoz Sucak AG. Acute physiological responses to physiotherapy applications pre and post autologous stem cell transplantation: an experimental study. Hematology. 2014 Apr;19(3):136-40.

Inamoto Y, Flowers ME, Sandmaier BM, Aki SZ, Carpenter PA, Lee SJ, Storer BE, Martin PJ. Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. Blood. 2014 Aug 21;124(8):1363-71.

Ilhan C, Suyanı E, Sucak GT, Paşaoğlu OT, Akı SZ, Paşaoğlu H. Inflammatory markers, oxidative stress, and antioxidant capacity in healthy allo-HSCT donors during hematopoietic stem cell mobilization. J Clin Apher. 2014 Sep 30.

Acar K, Akı ŞZ, Özkurt ZN, Bozdayı G, Rota S, Sucak GT. Factors Associated with Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: Human Leukocyte Antigens Might Be Among the Risk Factors Turk J Haematol 2014; 31(3): 276 – 285.

Tunccan OG, Dizbay M, Senol E, Aki Z, Ozdemir K. Isolated severe immune Thrombocytopenia due to acute brucellosis. Indian J Hematol Blood Transfus 2014; 30 (Suppl 1): 27- 9.

Akı ŞZ, Suyanı E, Cengiz M, Özenirler S, Elbeğ Ş, Paşaoğlu H, Sucak GT. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation. Biol Blood Marrow Transplant. 2015 Feb 11. pii: S1083-8791(15)00109-3. doi: 10.1016/j.bbmt.2015.02.002. [Epub ahead of print]

Camcıoğlu B, Boşnak-Güçlü M, Karadallı MN, Akı ŞZ, Türköz-Sucak G. The Role of Inspiratory Muscle Training in Sickle Cell Anemia Related Pulmonary Damage due to Recurrent Acute Chest Syndrome Attacks. Case Rep Hematol. 2015;2015:780159. doi: 10.1155/2015/780159

Barğı G, Güçlü MB, Arıbaş Z, Akı ŞZ, Sucak GT. Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial. Support Care Cancer. 2016 Feb;24(2):647-59.

Köktürk N, Yıldırım F, Aydoğdu M, Akı ŞZ, Yeğin ZA, Özkurt ZN, Suyanı E, Kıvılcım Oğuzülgen İ, Türköz Sucak G. Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels? Turk J Haematol. 2016 Mar 5;33(1):34-40.

Aki SZ, Inamoto Y, Carpenter PA, Storer BE, Sandmaier BM, Lee SJ, Martin PJ, Flowers ME. Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity. Bone Marrow Transplant. 2016 Oct;51(10):1350-1353.

Özkurt ZN, Sucak GT, Akı ŞZ, Yağcı M, Haznedar R. Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Cancer Invest. 2017 Mar 16;35(3):195-201.

Deger SM, Erten Y, Suyani E, Aki SZ, Ulusal Okyay G, Pasaoglu OT, Pasaoglu H, Arinsoy T, Turkoz Sucak G. Early Diagnostic Markers for Detection of Acute Kidney Injury in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Exp Clin Transplant. 2017 Apr 14. doi: 10.6002/ect.2016.0161. [Epub ahead of print]

Aypar E, İzzettin FV, Akı ŞZ, Sancar M, Yeğin ZA, Türköz Sucak G. Comparison of  conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High dose melphalan vs high dose melphalan and bortezomib. J Oncol Pharm Pract. 2017 Jan 1:1078155217697486. doi: 10.1177/1078155217697486. [Epub ahead of print]